Table 1.
Patient cohort and different RTX regimes (n = 76).
| Disease category | Patients | RTX interval | |
|---|---|---|---|
| 1-4 weeks | >4 weeks | ||
| Post-transplant lymphoproliferative disorder(5 after liver, 5 after kidney, 2 after bone marrow transplantation) | 12 | 11 | 1 |
| Monomorphic (Burkitt lymphoma or diffuse large-cell B cell lymphoma) | 9 | ||
| Polymorphic | 2 | ||
| Unknown | 1 | ||
| Organ transplant rejection(7 humoral, 1 cellular, 5 mixed cellular and humoral) | 13 | 0 | 13 |
| Liver transplantation | 3 | ||
| Kidney transplantation | 10 | ||
| Autoimmune diseases | 24 | 5 | 19 |
| Juvenile dermatomyositis | 2 | ||
| Granulomatosis with polyangiitis | 3 | ||
| Juvenile myasthenia gravis | 3 | ||
| Systemic lupus erythematosus with Shrinking lung disease | 1 | ||
| Atypical hemolytic uremic syndrome | 2 | ||
| Thrombotic-thrombocytopenic purpura | 1 | ||
| Anti-N-methyl-D-aspartate receptor (NMDAR)-encephalitis | 1 | ||
| Membrano-proliferative glomerulonephritis type 1 | 1 | ||
| Membrano-proliferative glomerulonephritis type 2 | 1 | ||
| Microscopic polyangiitis | 1 | ||
| Immunological disease associated with membrano-proliferativeglomerulonephritis type 1 | 1 | ||
| Haemophilia with inhibitors to factor VIII | 1 | ||
| Autoimmune hepatitis | 6 | ||
| Oncological diseases | 6 | 5 | 1 |
| Burkitt leukemia | 2 | ||
| Acute lymphatic leukemia | 1 | ||
| Mediastinal large B cell lymphoma | 1 | ||
| Diffuse large centroblastic B cell lymphoma | 1 | ||
| Unknown cervical lymphadenopathy | 1 | ||
| Nephrotic syndrome | 13 | 0 | 13 |
| Minimal-change glomerulonephritis (7 steroid-dependent, 2 steroid-sensitive) | 9 | ||
| Focal-segmental glomerulosclerosis (1 steroid-resistant) | 1 | ||
| Unknown | 3 | ||
| Other diseases* | 8 | 2 | 6 |
*
Other diseases (n = 8) were.